Paris, April 23rd , 2018 – LBO France is reinforcing its team. The company has recruited three new members since the beginning of the year in two of the company’s areas of expertise. Philippe Chambon and Sébastien Woynar have joined the Venture team, and Nicolas Manardo has joined the Small Cap team at the beginning of 2018.
The Venture team has welcomed Philippe Chambon in February 2018 as Venture Partner, and Sébastien Woynar in April 2018 as Director.
Philippe Chambon joined LBO France after a distinguished career in healthcare venture capital in the US. He started his business career in 1987 in the pharmaceutical industry, with Sandoz Pharmaceutical US affiliate and in 1993, he joined The Boston Consulting Group as a Manager. Starting from 1995, he has made numerous marquis name investments in the digital health sector over the years, first at The Sprout group, and then in 2005, with New Leaf Venture Partners. In his role of Managing Director, he led the fundraising effort of 4 funds totaling over $1billion. Philippe earned an MDPhD degree from the University Paris V and an MBA from Columbia University.
Sébastien Woynar has 15 years of international experience in the healthcare sector. Sebastien started his career in the healthcare public sector (French Ministry of Health and Paris University Hospitals General directorate) contributing to public health policies and healthcare organizational transformation. In 2010, Sebastien joined the home healthcare industry (Orkyn’, Air Liquide Healthcare) as Medical Director and then moving on to be Business Unit Director. Most recently Sebastien was Chronic Care Management Program Director and General Manager of CDM e-Health, a branch of Air Liquide Healthcare. Sebastien holds a Medical Degree from the University of Versailles-Saint Quentin in France and a Doctoral Degree in Public Health (Policy & Management) from the University of North Carolina at Chapel Hill in the USA. Sebastien was trained in health economics, policy and management at Harvard School of Public Health, at the London School of Economics and at Paris-Dauphine, as well as in strategy and marketing at ESSEC.
Valéry Huot, Partner, Head of the Venture team of LBO France said: “Our team historically holds a double expertise in medicine and technology and we are reinforcing it today with the recruitment of two new members with senior medical profiles. Phillipe has a background in Venture Capital in the US and Sébastien in the medical industry. These recruitments reflect our will to gather the best specialists to answer specific requests and issues regarding innovative SMEs in digital health, especially in the current fundraising context for our new fund, Digital Health 2.”
The Venture team of LBO France was created following the acquisition of Innovation Capital in May 2016 and holds a track record of 13 years and more than 100 investments, made or managed. There are now 9 team members which currently manages the only French fund 100% dedicated to the digital health sector.
Nicolas Manardo has joined the Small Cap investment team as Managing Director in January 2018.
Nicolas Manardo started his career in 2000 and has developed a solid experience in the field of investments. With Lazard (2000-2003) and the Société Générale (2006-2009), he has worked in M&A departments and has realized many operations for corporate clients and financial investors. Within the Saint Gobain Group (2003-2006), Nicolas has managed material distribution subsidiaries in France, Mexico and Italy. In 2009, he joined Bpifrance where he was put in charge of Mid Caps investment activities on equity and debt products starting from 2012. Nicolas has graduated from ESCP Europe, with a major in Legal and Financial Engineering and he is certified in Lean Management from the Ecole Centrale of Paris.
Jean-Marie Leroy, Partner, Head the Small Cap Investment team declared: “Nicolas’ arrival reinforces the team’s skills in terms of project origination and transaction structuring. This dual approach is essential to meet managers’ needs and support their growth projects over the long term.”
LBO France’s Small Cap team invests in growing French and Italian SMEs with strong international development potential. It now has 6 employees, including 3 based in Italy, and benefits from the support of the 6 members of LBO France’s transverse operational value creation team. 2017 was a very dynamic year with 3 investments made in the new Franco-Italian fund Small Caps Opportunities: Piex and Serapid in France and Vetroelite in Italy.
About LBO France
As a key player in private equity with €3.4bn of capital under management, LBO France is an independent company that has been supporting French and Italian companies in their growth for more than 30 years. Its strategy is based on 4 investment approaches in non-listed assets, managed by dedicated teams: (i) Mid Cap Buyout through the White Knight funds and Small Cap Buyout through the Hexagone/Small Caps Opportunities funds, (ii) Venture Capital through the Digital Health funds, (iii) Real Estate through the White Stone and Lapillus funds, (iv) Debt. LBO France is 100%-owned by its management and employs nearly 60 professionals.
Media contacts
Agence SHAN
Sophie Thiard – +33 1 42 86 82 43 – sophie.thiard@shan.fr
Léa Schultz – + 33 1 42 86 82 81 – lea.schultz@shan.fr